Las Vegas, NV -- (SBWIRE) -- 01/18/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Gilead Sciences, Inc. (NASDAQ:GILD) added 0.36% and is trading at $77.81. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions. The Company has operations in North America, Europe and Asia Pacific.
Can GILD Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=GILD
Affymax, Inc. (NASDAQ:AFFY) is lower 0.84% and is trading at $20.40. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.
Get Free Trend Analysis on AFFY Here http://beststocksdaily.com/p2/index.php?company=AFFY
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) added 0.23% and is trading at $21.90. Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). Its Alnylam 5x15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases.
To Get complete technical analysis on ALNY go to http://beststocksdaily.com/p2/index.php?company=ALNY
Theravance Inc (NASDAQ:THRX) fell 0.17% and is trading at $20.93. Theravance, Inc. operates as a biopharmaceutical company. The Company is focusing on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, overactive bladder, and gastrointestinal disorders.
Get Free Trend Analysis on THRX Here http://beststocksdaily.com/p2/index.php?company=THRX
Anika Therapeutics, Inc. (NASDAQ:ANIK) is higher 0.19% and is trading at $10.31. Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika’s wholly owned subsidiary, Anika Therapeutics S.r.l., had over 20 products commercialized, primarily in Europe. These products are also all made from hyaluronic acid, based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
To Get complete technical analysis on ANIK go to http://beststocksdaily.com/p2/index.php?company=ANIK
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)